Latest MS research news

Latest MS research news | 23 April 2013

Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

This study from the US looked at the association between serum lipid profile with disease progression in high-risk clinically isolated syndromes (CIS) with CSF ...

From MSIF

Latest MS research news | 23 April 2013

Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study

In this population-based study from the Netherlands, the researchers looked at the relationship between amyotrophic lateral sclerosis (ALS) and MS.

From MSIF

Latest MS research news | 23 April 2013

Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors

The researchers explored if loss of hippocampal myelin alters expression of neuronal microRNAs (miRNAs), by comparing miRNA profiles from myelinated ...

From MSIF

Latest MS research news | 15 April 2013

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

This study group reports the results of their 52-week, randomised, placebo-controlled, dose ranging, phase 2 study of daclizumab high-yield process (HYP) in RRMS.

From MSIF

Latest MS research news | 15 April 2013

Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study

This study group from Italy explored the contribution of local and distant mechanisms associated with optic radiation (OR) damage in MS.

From MSIF

Latest MS research news | 15 April 2013

Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study

This study tested the cognitive reserve (CR) hypothesis in the model of MS by assessing the interactions among CR, brain atrophy and cognitive efficiency in patients with RRMS.

From MSIF

Latest MS research news | 09 April 2013

Childhood body mass index and multiple sclerosis risk: a long-term cohort study

This prospective study from the US examined if body mass index (BMI) at ages 7-13 years was associated with MS risk among 302,043 individuals.

From MSIF

Latest MS research news | 09 April 2013

Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples

This paper looks at the association between antibody reactivity against Epstein-Barr nuclear antigen-1 (EBNA-1) and five EBNA-1 domains and the risk of MS.

From MSIF

Latest MS research news | 09 April 2013

Low myo-inositol indicating astrocytic damage in a case series of NMO

This study looked at five Neuromyelitis Optica (NMO)-related cases, with longitudinally extensive lesions in the upper cervical cord who underwent 1 H-MR spectroscopy of the cervical cord.

From MSIF

Latest MS research news | 02 April 2013

Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS

This study group used data from two phase III clinical trials of dalfampridine (fampridine outside the US) in 533 patients with MS and looked at the clinical meaningfulness of the Timed 25-Foot Walk (T25FW) changes.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research

Atacicept in multiple sclerosis: a randomised, placebo-controlled, double-blind, phase 2 trial